Ginkgo Bioworks is the “Organism Company”, enabling the growth of biotechnology across diverse markets. Already valued at $15B, Ginko is not only giving Biology a technological makeover; they are educating industries on the fact that “programming in the 21st century isn’t going to be computers — it’s biology.” 

Here are ten facts you should know about Ginkgo Bioworks:

1. Boston-based Ginkgo Bioworks has been programming cells since 2009.
2. Soaring Eagle announced it would merge with Ginkgo in a deal that valued the Boston company at $15 billion. 
3. In 2020 Ginkgo brought in $77 million providing research services and covid-19 tests.
4. Ginkgo Bioworks is proving that biology is a much more powerful manufacturing platform than most realised.
5. Embodying the most significant trends in DNA science, it is believed that Ginkgo will become the Intel, Microsoft, or Amazon of biology.
6. Ginkgo’s multibillion-dollar offering is a milestone in maturing synthetic biology from a science to a true industry.
7. Ginkgo’s CEO Jason Kelly believes, “What computers did for information, biology will do for the physical world”.
8. Ginkgo recently began trading on the New York Stock Exchange under the ticker symbol “DNA”. Their shares rose 6.6% on its first trading day, giving it a market cap of $2.6 billion.
9. Ginkgo’s artisanal craft of manipulating biology is not driven by making products of its own but serves as a research platform for the entire synthetic biology industry.
10. Ginkgo plans to close new cell programs and has so far added 30 programs this year.

Share Your Tips & Corrections